What does Univercells do?
UNIVERCELLS is a biotechnology company specializing in the development and manufacturing of advanced bioprocessing solutions. The company focuses on streamlining the production of viral vectors and vaccines, enhancing efficiency and scalability. By leveraging innovative technologies, UNIVERCELLS aims to accelerate the delivery of life-saving therapies to patients worldwide.
- Signals
-
Reporting lossesReporting losses € -9.95M
The company reported a loss in the latest financial year.
Negative EBITDANegative EBITDA € -4.98MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 142.84MStrong equity provides a buffer against setbacks.
Low riskLow risk 61.7%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 2.58A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 25.41MPositive operating cash flow in the latest financial year.
High turnoverHigh turnover € 18.28MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 18.0%Social debts stay manageable relative to personnel costs.
- Investments
- Exothera 100%, Unizima 100%, Quantoom Biosciences 100%, +2 more
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2021
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2017
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
18.28M
|
€
21.40M
|
€
15.35M
|
€
923K
|
|
|
€
-4.98M
|
€
-8.50M
|
€
-6.92M
|
€
-3.08M
|
|
|
€
20.44M
|
€
-6.75M
|
€
-8.30M
|
€
-3.60M
|
|
|
€
142.84M
|
€
109.17M
|
€
71.57M
|
€
1.49M
|
|
|
61.67%
|
57.38%
|
50.88%
|
12.51%
|
|
|
€
88.78M
|
€
81.09M
|
€
69.11M
|
€
10.37M
|
|
|
€
3.29M
|
€
6.72M
|
€
14.19M
|
€
1.94M
|
|
|
86.30
|
88.10
|
63.70
|
32.70
|
Publications 37
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 29/06/2023
- Demissions, Nominations 21/04/2023
- Divers 25/01/2023
- Capital, Actions 11/01/2023
- Capital, Actions 17/10/2022
News
Show all- Univercells: Revolutionizing Biotech With Affordable Vaccine Production And Innovative Business Models Dealroom 5 months ago
- Univercell Lands €30M Series B To Advance European Lithium-Ion Cell Manufacturing Tech.eu 7 months ago
- Univercells Appoints Douglas A. Neugold As Chairman Of Its Board Of Directors Manufacturing Chemist 1 year ago
- Fund Linked To Bill Gates Could Save Walloon Biotech Company The Brussels Times 1 year ago
- Repligen And Univercells Partner To Enable Real-Time Viral Vector And Vaccine Biomanufacturing Monitoring Genetic Engineering and Biotechnology News 1 year ago
Frequently asked questions
Answers to the most common questions about Univercells, based on official government data and the filed annual accounts.
What is the VAT number of Univercells?
The VAT number of Univercells is BE0502.742.288.
What is the official website of Univercells?
The official website of Univercells is http://www.univercells.com.
How many employees work at Univercells?
In 2023, Univercells employed 86.30 full-time equivalents (FTE).
When was Univercells established?
Univercells was founded in 23-01-2013.
What is the official address of Univercells?
The official address of Univercells is Zoning De Jumet,Avenue Centrale 52 Charleroi 6040.
What is the legal form of Univercells?
The juridical form of Univercells is Public limited company (NV/SA).
What is the annual revenue of Univercells?
The revenue of Univercells for the 2023 financial year was €18,276,349.
What does Univercells do?
UNIVERCELLS is a biotechnology company specializing in the development and manufacturing of advanced bioprocessing solutions. The company focuses on streamlining the production of viral vectors and vaccines, enhancing efficiency and scalability. By leveraging innovative technologies, UNIVERCELLS aims to accelerate the delivery of life-saving therapies to patients worldwide.
Is Univercells a reliable company?
Univercells is a registered Rechtspersoon with company number 0502.742.288 and can be verified through the official CBE database.
What is the credit limit of Univercells?
The estimated credit limit of Univercells is €7,186,323.
Is Univercells still active?
Univercells currently has the status "Normal situation" and is active.